CCG reports

CCG publishes vision for future of cancer services

The CCG has published six documents setting out our vision for the future of cancer services.  The documents are available here:

We hope that these visions will help to inform the development of future cancer services.  If you have any questions, or would like further information, then please email ccg@mhpc.com.

______________________________________________________________________

GPs say they need specialist advice to effectively commission cancer services (May 2011)

The Cancer Campaigning Group's report Ensuring effective commissioning of cancer services – A survey of GPs found that four in five (82%) GPs believe that GP commissioners will need specialist support if they are to commission cancer services effectively. Most GPs (71%) believe they, as individuals, will require specialist advice to effectively commission cancer services. The findings come from research into GPs' views on specialist commissioning support, carried out by ComRes.

These findings suggest that the quality of care cancer patients get could be adversely affected by the Government’s health reforms if GPs cannot access the commissioning support they need. The CCG believes cancer networks are ideally placed to provide this support. The cancer community is therefore calling for continued funding for cancer networks until GP consortia are fully up and running, with a commitment from the NHS Commissioning Board to retain their expertise for the longer-term.

Cancer Campaigning Group Steering Group member, Mia Rosenblatt said:

“It is critical that during this period, when the Government is listening to what people want from a reformed NHS, the Prime Minister and Health Secretary examine these insights from GPs and work with the cancer community to ensure cancer services continue to improve and deliver better outcomes and experiences for patients.”

The full data tables are available here and the full briefing is available here.

For more information on this briefing or for further information on the work of the CCG, please email ccg@mhpc.com or telephone 020 3128 8108.

It is supported by 12 companies:

  • Amgen
  • Astra Zeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • GE Healthcare
  • GSK
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Sanofi Aventis